Literature DB >> 7570350

Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons.

J I Engelhardt1, L Siklós, L Kömüves, R G Smith, S H Appel.   

Abstract

Antibodies to Ca channels in ALS patients IgG can be demonstrated to enhance Ca current and cause cell injury and death in a motoneuron cell line in vitro. To determine whether these antibodies can alter neuronal calcium homeostasis in vivo IgG fractions from six ALS patients were injected intraperitoneally into mice, and neurons assayed by ultrastructural techniques for calcium content. After 24 h, all six ALS IgG by (40 mg/animal) increased vesicle number in spinal motoneuron axon terminals, and in boutons synapsing on spinal motoneurons. Using the oxalate-pyroantimonate technique for calcium precipitation, these antibodies produced dose-dependent calcium increases either in axon terminal synaptic vesicles and mitochondria, or in rough endoplasmic reticulum, mitochondria, and Golgi complex of spinal motoneuron and frontal cortex pyramidal cells. ALS IgG was itself internalized and also induced neurofilament H phosphorylation. The observed changes in ultrastructure and calcium compartmentation were restricted to motoneurons; normal and disease control IgG, which did not possess antibodies enhancing calcium entry, did not exert similar effects. These data demonstrate that ALS IgG containing Ca-channel antibodies can alter calcium homeostasis of motoneurons in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570350     DOI: 10.1002/syn.890200302

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  20 in total

1.  Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity.

Authors:  B K Ho; M E Alexianu; L V Colom; A H Mohamed; F Serrano; S H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 2.  Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Authors:  Grace E Stutzmann; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

3.  Differential localization of voltage-dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction.

Authors:  N C Day; S J Wood; P G Ince; S G Volsen; W Smith; C R Slater; P J Shaw
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

4.  Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.

Authors:  Elsa Tremblay; Éric Martineau; Richard Robitaille
Journal:  J Neurosci       Date:  2017-08-11       Impact factor: 6.167

Review 5.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals.

Authors:  Mario R Pagani; Ricardo C Reisin; Osvaldo D Uchitel
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

7.  Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis.

Authors:  Ursula Muñoz; Cristina Sebal; Esther Escudero; Margaret Esiri; John Tzartos; Carolyn Sloan; Mari Cruz Sadaba
Journal:  Cell Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.046

8.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

Review 9.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

10.  Calcium signaling in neurodegeneration.

Authors:  Philippe Marambaud; Ute Dreses-Werringloer; Valérie Vingtdeux
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.